Ocumension Therapeutics (FRA:5DG)

Ocumension Therapeutics Revenue

Ocumension Therapeutics had revenue of 294.03M CNY in the half year ending June 30, 2025, with 183.55% growth. This brings the company's revenue in the last twelve months to 543.72M, up 75.23% year-over-year. In the year 2024, Ocumension Therapeutics had annual revenue of 417.31M with 69.38% growth.

• Revenue (ttm): 543.72M CNY
• Revenue Growth: +75.23%
• P/S Ratio: 10.05
• Revenue / Employee: 1.08M CNY
• Employees: 505
• Market Cap: 649.42M EUR

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	417.31M	170.94M	69.38%
Dec 31, 2023	246.37M	87.41M	54.99%
Dec 31, 2022	158.96M	102.81M	183.11%
Dec 31, 2021	56.15M	43.05M	328.73%
Dec 31, 2020	13.10M	12.91M	6,792.63%